Literature DB >> 6415234

Characteristics of a high molecular weight extracellular protein of Streptococcus mutans.

H Forester, N Hunter, K W Knox.   

Abstract

A high molecular weight protein antigen, designated P1, has been isolated from the culture fluid of chemostat-grown Streptococcus mutans strain Ingbritt and shown to be free of other antigens including glucosyltransferase. Antiserum against the protein was used in rocket immunoelectrophoresis to confirm and extend the previous observation that there were major differences in the amount of the protein produced under different growth conditions. Physico-chemical and serological studies indicated that protein P1 was indistinguishable from antigens B, I/II and IF isolated in other laboratories. Mammalian tissue cross-reactivity of protein P1 was demonstrated by binding of antiserum to P1 to sections of normal rabbit tissues, particularly heart. There was also a statistically significant increase in the number of mononuclear leucocytes in heart tissue of rabbits which had been injected with protein P1, when compared with the levels in control uninjected rabbits; injection with whole cells of S. mutans Ingbritt did not produce this effect.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6415234     DOI: 10.1099/00221287-129-9-2779

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  65 in total

1.  Immunogenicity of peptides coupled with multiple T-cell epitopes of a surface protein antigen of Streptococcus mutans.

Authors:  H Senpuku; T Iizima; Y Yamaguchi; S Nagata; Y Ueno; M Saito; N Hanada; T Nisizawa
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

2.  Flagellin-rPAc vaccine inhibits biofilm formation but not proliferation of S. mutans.

Authors:  Ying Sun; Yi Yang; Dihan Zhou; Yuan Cao; Jie Yu; Bali Zhao; Maohua Zhong; Yaoming Li; Jingyi Yang; Huimin Yan
Journal:  Hum Vaccin Immunother       Date:  2016-07-08       Impact factor: 3.452

3.  Restriction fragment length polymorphisms and sequence variation within the spaP gene of Streptococcus mutans serotype c isolates.

Authors:  L J Brady; P J Crowley; J K Ma; C Kelly; S F Lee; T Lehner; A S Bleiweis
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

4.  Complete nucleotide sequence of the gene for a surface protein antigen of Streptococcus sobrinus.

Authors:  M Tokuda; N Okahashi; I Takahashi; M Nakai; S Nagaoka; M Kawagoe; T Koga
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

5.  Further characterization of immunomodulation by a monoclonal antibody against Streptococcus mutans antigen P1.

Authors:  Nikki R Rhodin; Marloes L J A Van Tilburg; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Structural studies of the rhamnose-glucose polysaccharide antigen from Streptococcus sobrinus B13 and 6715-T2.

Authors:  R Linzer; M S Reddy; M J Levine
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

7.  Deletion of the central proline-rich repeat domain results in altered antigenicity and lack of surface expression of the Streptococcus mutans P1 adhesin molecule.

Authors:  L J Brady; D G Cvitkovitch; C M Geric; M N Addison; J C Joyce; P J Crowley; A S Bleiweis
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Identification of antigenic epitopes in an alanine-rich repeating region of a surface protein antigen of Streptococcus mutants.

Authors:  N Okahashi; I Takahashi; M Nakai; H Senpuku; T Nisizawa; T Koga
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

9.  Identification of Streptococcus mutans PAc peptide motif binding with human MHC class II molecules (DRB1*0802, *1101, *1401 and *1405).

Authors:  H Senpuku; K Yanagi; T Nisizawa
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

10.  Differentiation of salivary agglutinin-mediated adherence and aggregation of mutans streptococci by use of monoclonal antibodies against the major surface adhesin P1.

Authors:  L J Brady; D A Piacentini; P J Crowley; P C Oyston; A S Bleiweis
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.